Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) Short Interest Down 66.9% in March

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) saw a significant decline in short interest in March. As of March 15th, there was short interest totalling 4,900 shares, a decline of 66.9% from the February 28th total of 14,800 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 15,100 shares, the short-interest ratio is currently 0.3 days.

Analysts Set New Price Targets

Separately, Maxim Group lowered their price objective on Cryo-Cell International from $9.00 to $8.50 and set a “buy” rating for the company in a research note on Tuesday, March 4th.

Hedge Funds Weigh In On Cryo-Cell International

A number of hedge funds have recently added to or reduced their stakes in the stock. Geode Capital Management LLC boosted its holdings in shares of Cryo-Cell International by 68.5% in the third quarter. Geode Capital Management LLC now owns 39,860 shares of the company’s stock valued at $254,000 after purchasing an additional 16,203 shares during the period. Rowlandmiller & PARTNERS.ADV bought a new position in shares of Cryo-Cell International during the 4th quarter worth $107,000. Heron Bay Capital Management bought a new position in shares of Cryo-Cell International during the 4th quarter worth $235,000. CreativeOne Wealth LLC purchased a new position in shares of Cryo-Cell International during the fourth quarter valued at $113,000. Finally, Topline Capital Management LLC bought a new stake in shares of Cryo-Cell International in the fourth quarter valued at about $354,000. 10.44% of the stock is currently owned by institutional investors.

Cryo-Cell International Stock Down 1.9 %

CCEL stock traded down $0.12 during mid-day trading on Friday, reaching $6.30. 8,537 shares of the stock traded hands, compared to its average volume of 12,457. Cryo-Cell International has a one year low of $5.75 and a one year high of $9.50. The stock has a market capitalization of $50.78 million, a price-to-earnings ratio of -5.94 and a beta of 0.53.

Cryo-Cell International Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 15.87%. The ex-dividend date of this dividend was Friday, February 14th. Cryo-Cell International’s dividend payout ratio is presently -94.34%.

About Cryo-Cell International

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.